FineMark National Bank & Trust’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $219K | Buy |
+4,472
| New | +$209K | 0.01% | 417 |
|
|
2025
Q1 | – | Sell |
-6,091
| Closed | -$206K | – | 455 |
|
|
2024
Q4 | $206K | Buy |
6,091
+240
| +4% | +$8.64K | 0.01% | 408 |
|
|
2024
Q3 | $239K | Buy |
+5,851
| New | +$239K | 0.01% | 379 |
|
|
2024
Q2 | – | Sell |
-4,777
| Closed | -$205K | – | 438 |
|
|
2024
Q1 | $205K | Buy |
+4,777
| New | +$197K | 0.01% | 404 |
|
|
2023
Q3 | – | Sell |
-5,811
| Closed | -$207K | – | 423 |
|
|
2023
Q2 | $207K | Sell |
5,811
-108
| -2% | -$3.87K | 0.01% | 401 |
|
|
2023
Q1 | $211K | Sell |
5,919
-68
| -1% | -$2.38K | 0.01% | 388 |
|
|
2022
Q4 | $210K | Buy |
+5,987
| New | +$199K | 0.01% | 380 |
|
|
2022
Q3 | – | Sell |
-4,827
| Closed | -$263K | – | 400 |
|
|
2022
Q2 | $263K | Sell |
4,827
-3
| -0.1% | -$166 | 0.01% | 356 |
|
|
2022
Q1 | $263K | Hold |
4,830
| – | – | 0.01% | 387 |
|
|
2021
Q4 | $266K | Sell |
4,830
-512
| -10% | -$26.6K | 0.01% | 400 |
|
|
2021
Q3 | $255K | Sell |
5,342
-2,186
| -29% | -$110K | 0.01% | 389 |
|
|
2021
Q2 | $375K | Sell |
7,528
-386
| -5% | -$18.5K | 0.02% | 331 |
|
|
2021
Q1 | $353K | Buy |
7,914
+216
| +3% | +$9.8K | 0.01% | 326 |
|
|
2020
Q4 | $354K | Buy |
7,698
+2,026
| +36% | +$93.1K | 0.02% | 311 |
|
|
2020
Q3 | $267K | Sell |
5,672
-156
| -3% | -$7.82K | 0.01% | 319 |
|
|
2020
Q2 | $297K | Hold |
5,828
| – | – | 0.02% | 298 |
|
|
2020
Q1 | $276K | Hold |
5,828
| – | – | 0.02% | 280 |
|
|
2019
Q4 | $342K | Sell |
5,828
-440
| -7% | -$24.5K | 0.02% | 293 |
|
|
2019
Q3 | $334K | Buy |
6,268
+341
| +6% | +$17.5K | 0.02% | 286 |
|
|
2019
Q2 | $297K | Buy |
5,927
+802
| +16% | +$40.2K | 0.02% | 296 |
|
|
2019
Q1 | $268K | Sell |
5,125
-513
| -9% | -$25.6K | 0.02% | 291 |
|
|
2018
Q4 | $269K | Buy |
5,638
+286
| +5% | +$14.1K | 0.02% | 285 |
|
|
2018
Q3 | $269K | Buy |
+5,352
| New | +$272K | 0.02% | 270 |
|
|
2015
Q4 | – | Sell |
-14,212
| Closed | -$683K | – | 1406 |
|
|
2015
Q3 | $683K | Sell |
14,212
-526
| -4% | -$27.4K | 0.09% | 166 |
|
|
2015
Q2 | $767K | Buy |
14,738
+328
| +2% | +$18.5K | 0.1% | 173 |
|
|
2015
Q1 | $831K | Sell |
14,410
-1,025
| -7% | -$58.8K | 0.11% | 164 |
|
|
2014
Q4 | $825K | Buy |
15,435
+1,589
| +11% | +$88.9K | 0.12% | 159 |
|
|
2014
Q3 | $795K | Buy |
13,846
+1,023
| +8% | +$62.7K | 0.13% | 153 |
|
|
2014
Q2 | $857K | Sell |
12,823
-526
| -4% | -$35.6K | 0.14% | 146 |
|
|
2014
Q1 | $891K | Buy |
13,349
+2,377
| +22% | +$161K | 0.17% | 137 |
|
|
2013
Q4 | $732K | Buy |
10,972
+798
| +8% | +$51.7K | 0.15% | 144 |
|
|
2013
Q3 | $639K | Sell |
10,174
-658
| -6% | -$42.4K | 0.16% | 136 |
|
|
2013
Q2 | $682K | Buy |
+10,832
| New | +$688K | 0.21% | 101 |
|
Other funds holding GSK
JEST
